What is figaro dkd?
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Is Finerenone FDA approved?
The US Food and Drug Administration (FDA) approved finerenone (Kerendia), the first agent from a new class of nonsteroidal mineralocorticoid receptor antagonists (MRAs), on July 9 for treating patients with chronic kidney disease (CKD) associated with type 2 diabetes.
What is the difference between spironolactone and Finerenone?
Unlike spironolactone and eplerenone, which have a higher tendency to focus on the kidney rather than the heart, finerenone has the same tendency in heart and kidney tissues. Finerenone is currently the most advanced third generation non-steroidal MRAs drug.
Why are SGLT2 renoprotective?
Also, these clinical evidences have shown other renoprotective effects of SGLT2i by lowering the body weight, reduction in albuminuria, regulating urinary albumin/creatinine ratio and improvement in renal cells’ morphology and lower histological damages leading to improved eGFR in evaluated populations.
What is finerenone used for?
Finerenone is used to treat adults with chronic kidney disease (damage to the kidneys which may worsen over time and may cause the kidneys to stop working) due to type 2 diabetes.
Does Bayer make finerenone?
Berlin, July 9th, 2021 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved finerenone, the first non-steroidal, selective mineralocorticoid receptor (MR) antagonist, under the brand name Kerendia®.
Is finerenone like eplerenone?
Eplerenone, as well as spironolactone distribute several fold greater to the kidneys than the heart – whereas finerenone is equally distributed to the kidney and heart —thereby providing relatively greater cardiac vs renal protection.
What is the difference between dapagliflozin and empagliflozin?
More specifically, empagliflozin was more effective in reducing HbA1c and improving other cardiometabolic parameters than dapagliflozin.
How many SGLT2 inhibitors are there?
Currently there are three SGLT2 selective inhibitors approved by the Food and Drug Administration (FDA) for mono, dual, and triple therapy: canagliflozin (Invokana®), dapagliflozin (Farxiga®) and empagliflozin (Jardiance®) (5, 11, 12).
What drug class is finerenone?
Finerenone is in a class of medications called mineralocorticoid receptor (MR) antagonists. It works by blocking the activity of certain steroids made in the body that can damage the heart and kidneys.
Is finerenone available?
Currently, finerenone is planned to be available in the United States at the end of July 2021. Additionally, finerenone has been submitted by Bayer for marketing authorization in the European Union.
